Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients

Pediatric Transplantation

Volumn 9, Issue 4, 2005, Pages 456-463

  Oberholzer, José ^a   John, Eunice ^a   Lumpaopong, Adisorn ^a   Testa, Giuliano ^a   Sankary, Howard N ^a   Briars, Leslie ^a   Kraft, Kerri A ^a   Knight, Peter S ^a   Verghese, Priya ^a   Benedetti, Enrico ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cushingoid; Growth; Kidney transplant; Pediatric; Steroid discontinuation; Steroid withdrawal; Steroids

Indexed keywords

ACICLOVIR; AZATHIOPRINE; BASILIXIMAB; CEFALEXIN; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ADOLESCENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CUSHINGOID SYNDROME; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT SURVIVAL; GROWTH RETARDATION; HLA MATCHING; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PILOT STUDY; PNEUMOCYSTOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; STEROID THERAPY; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; AZATHIOPRINE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MUROMONAB-CD3; MYCOPHENOLIC ACID; PILOT PROJECTS; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; STEROIDS; SURVIVAL RATE; TACROLIMUS;

EID: 23844524115     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00319.x     Document Type: Article

References (23)

1. TONSHOFF B, MEHLS O. Factors affecting growth and strategies for treatment in children after renal transplantation. Pediatr Transplant 1997: 1: 176-182.
2. VEENSTRA DL, BEST JH, HORNBERGER J, SULLIVAN SD, HRICIK DE. Incidence and long-term cost of steroid-related side-effects after renal transplantation. Am J Kidney Dis 1999: 33: 829-839.
3. HRICIK DE, ALMAWI WY, STROM TB. Trends in the use of glucocorticoids in renal transplantation. Transplantation 1994: 57: 979-989.
4. TARANTINO A, MONTAGNINO G, PONTICELLI C. Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation. Drug Saf 1995: 13: 145-156.
5. HRICIK DE. Steroid-free immunosuppression in kidney transplantation: an editorial review. Am J Transplant 2002: 2: 19-24.
6. HRICIK DE, O'TOOLE MA, SCHULAK JA, HERSON J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993: 4: 1300-1305.
7. KASISKE BL, CHAKKERA HA, Louis TA, MA JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000: 11: 1910-1917.
8. RATCLIFFE PJ, DUDLEY CR, HIGGINS RM, FIRTH JD, SMITH B, MORRIS PJ. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996: 348: 643-648.
9. BROYER M, GUEST G, GAGNADOUX MF. Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation. J Pediatr 1992: 120: 721-725.
10. ROBERTI I, REISMAN L, LIEBERMAN KV, BURROWS L. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up). Clin Transplant 1994: 8: 405-408.
11. BIRKELAND SA, LARSEN KE, ROHR N. Pediatric renal transplantation without steroids. Pediatr Nephrol 1998: 12: 87-92.
12. SARWAL MM, YORGIN PD, ALEXANDER S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001: 72: 13-21.
13. MATAS AJ, RAMCHARAN T, PARASKEVAS S, et al. Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study. Am J Transplant 2001: 1: 278-283.
14. SCHWARTZ GJ, FELD LG, LANGFORD DJ. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 1984: 104: 849-854.
15. SCHWARTZ GJ, GAUTHIER B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985: 106: 522-526.
16. SEIKALY M, Ho PL, EMMETT L, TEJANI A. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1988. Pediatr Transplant 2001: 5: 215-231.
17. SARWAL MM, VIDHUN JR, ALEXANDER SR, SATTERWHITE T, MILLAN M, SALVATIERRA O Jr. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003: 76: 1331-1339.
18. ASKAR I, BOZKURT M. Protective effects of immunosuppressants and steroids against ischemia-reperfusion injury in cremaster muscle flap at microcirculatory level. Microsurgery 2002: 22: 361-366.
19. FINE RN, HO M, TEJANI A. The contribution of renal transplantation to final adult height: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 2001: 16: 951-956.
20. JABS K, SULLIVAN EK, AVNER ED, HARMON WE. Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1996: 61: 31-36.
21. ELLIS D. Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants. Pediatr Nephrol 2000: 14: 689-694.
22. JINDAL RM, SIDNER RA, MILGROM ML. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 1997: 16: 242-257.
23. BAID-AGRAWAL S, DELMONICO FL, TOLKOFF-RUBIN NE, et al. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. Transplantation 2004: 77: 1199-1202.